as on December 26, 2025 at 4:01 pm IST
Day's High
0.51%
Upside
52 Week's Low
52 Week's High
20.25%
Downside
68.66%
Upside
as on December 26, 2025 at 4:01 pm IST
Market Cap
₹65.28 Cr
Return on Equity (ROE)
16.88
PE Ratio (TTM)
27.22
Return on capital employed (ROCE)
11.71
Industry PE ratio
49.42
Beta (LTM)
0.37
P/B Ratio
12.04
Dividend Yield
0PEG Ratio
7.84
Quarterly Earnings Growth YOY
740
EPS (TTM)
1.97
Sector
Healthcare
Book Value
7.03
Technical Analysis
Bearish
View Technical Analysis
as on December 26, 2025 at 4:01 pm IST
Aspira Pathlab in the last 5 years
Lowest (-433.33x)
November 29, 2024
Today (27.22x)
December 26, 2025
Industry (49.42x)
December 26, 2025
Highest (124.02x)
March 24, 2025
Today’s Price to Earnings Ratio: 27.22x
Compare market cap, revenue, PE, and other key metrics of Aspira Pathlab with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 65.28 | 27.42% | 0.58 | 2 | 22 | |
| BUY | 4,180.75 | 136.05% | 0.00 | 160 | 1,356 | |
| NA | 112.19 | 3.07% | 0.50 | 45 | 59 | |
| BUY | 2,372.08 | -5.18% | 0.60 | 77 | 723 | |
| NA | 37.74 | -11.02% | 0.51 | 1 | 75 |
Get share price movements and forecasts by analysts on Aspira Pathlab.
Source: S&P Global Market Intelligence
Search interest for Aspira Pathlab & Diagnostics Ltd Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:31% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Aspira Pathlab.
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 740% since last year same period to ₹0.42Cr in the Q1 2025-2026. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated -38.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Aspira Pathlab stock has moved up by 2.1%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 81.61% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Fortis Healthcare Ltd has given 220.7% return, outperforming this stock by 162.8%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 18.39% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Narayana Hrudayalaya Ltd has given 43.3% return, outperforming this stock by 36.0%
| Organisation | Aspira Pathlab & Diagnostics Ltd |
| Headquarters | Mumbai |
| Industry | Healthcare |
| CEO | Haseeb Drabu |
| E-voting on shares | Click here to vote |
Aspira Pathlab share price today stands at ₹63.31 as on at the close of the market. Aspira Pathlab share today touched a day high of ₹63.63 and a low of ₹63.31.
Aspira Pathlab touched a 52 week high of ₹106.78 and a 52 week low of ₹50.49. Aspira Pathlab share price today i.e. is closed at ₹63.31, which is -40.71% down from its 52 week high and 25.39% up from its 52 week low.
Aspira Pathlab market capitalisation is ₹65.28 Cr as on .
To buy Aspira Pathlab shares, you need to follow these steps:
Aspira Pathlab trading volume is 20.00 as on . This means that 20.00 shares of Aspira Pathlab were bought and sold on the stock market during today's trading session.